Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor.
Mayan
H
H
Department of Medicine E, Chaim Sheba Medical Center, Tel-Aviv University, Tel Hashomer, Israel.
Hourvitz
A
A
Schiff
E
E
Farfel
Z
Z
D000328:Adult; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000150:complications*; D007011:Hypoparathyroidism / Q000150:complications*; D007213:Indomethacin / Q000627:therapeutic use; D008274:Magnesium / Q000009:adverse effects* / Q000097:blood*; D009543:Nifedipine / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications; D044169:Receptors, Calcium-Sensing; D011956:Receptors, Cell Surface / Q000378:metabolism*; D015145:Tocolysis / Q000009:adverse effects*; D015149:Tocolytic Agents / Q000627:therapeutic use; D014427:Twins
D010281:Parathyroid Hormone; D044169:Receptors, Calcium-Sensing; D011956:Receptors, Cell Surface; D015149:Tocolytic Agents; D008274:Magnesium; D009543:Nifedipine; D002118:Calcium; D007213:Indomethacin